ctrl K

60 Degrees Pharmaceutical... (SXTP)

NASDAQ: SXTP · Real-Time Price · USD

2.25

-0.23 (-9.27%)

At close: May 02, 2025, 3:59 PM

60 Degrees Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	607.57K	253.57K	223.21K	1.16M	2.18M
Cost of Revenue	384.76K	474.55K	432.37K	850.74K	702.99K
Gross Profit	222.81K	-220.98K	-209.16K	309.6K	1.48M
Operating Income	-9.71M	-5.15M	-1.75M	-1.12M	-418.13K
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.96M	-3.81M	-6.18M	-4.26M	-3.05M
Net Income	-7.95M	-3.77M	-6.18M	-4.25M	-3.03M
Selling & General & Admin	5.02M	4.24M	1.3M	1.12M	1.46M
Research & Development	4.99M	691.77K	237.56K	318.35K	438.58K
Other Expenses	-73.77K	n/a	-43.24K	37.52K	-121
Operating Expenses	9.94M	4.93M	1.54M	1.43M	1.85M
Interest Expense	7.91K	2.29M	3.99M	3.17M	2.68M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	10.4M	5.41M	1.97M	2.28M	2.55M
Income Tax Expense	250.00	250.00	500.00	1K	1K
Shares Outstanding (Basic)	454.58K	3.96M	5.78M	5.78M	5.78M
Shares Outstanding (Diluted)	454.58K	3.96M	5.78M	5.78M	5.78M
EPS (Basic)	-17.48	-0.95	-1.07	-0.74	-0.52
EPS (Diluted)	-17.48	-0.95	-1.07	-0.74	-0.52
EBITDA	-7.88M	-1.43M	-2.11M	-1.01M	-341.17K
EBIT	-7.95M	-1.53M	-2.19M	-1.09M	-369.04K
Depreciation & Amortization	63.74K	100.37K	78.79K	71.78K	27.86K